{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:26:15Z","timestamp":1777422375699,"version":"3.51.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Opioids are commonly prescribed to women of reproductive age, including after delivery and miscarriage. However, to our knowledge, opioid use has not been frequently studied in relation to the common reproductive complications of impaired fecundability and pregnancy. We examined the association of opioid use during the critical window of pregnancy establishment with fecundability and pregnancy loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We measured opioid use by urine screening and self-report at multiple time points during preconception and early pregnancy in a prospective cohort of women attempting conception (n = 1228). The main outcomes included time to hCG-detected pregnancy and incidence of live birth and pregnancy loss. We estimated fecundability odds ratios and risk ratios (RR) with 95% confidence intervals (CI) adjusting for sociodemographic characteristics, reproductive characteristics, and use of antidepressants, tobacco, alcohol, and marijuana.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Prevalence of preconception opioid use was 18% (n = 226 of 1228), and in early pregnancy was 5% (n = 33 of 685). Opioid use while attempting pregnancy was associated with reduced fecundability (fecundability odds ratios: 0.71; 95% CI = 0.50, 1.0). Risk of pregnancy loss increased as opioid exposure was detected later in gestation, from the beginning of the cycle of conception (RR: 1.5; 95% CI 0.85, 2.6), to week 4 of pregnancy (RR: 2.1; 95% CI = 1.1, 4.1), and to week 4 and 8 of pregnancy (RR: 2.5; 95% CI = 1.3, 5.0).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our results are consistent with the hypothesis that opioid exposure while trying to conceive may be harmful, even among healthy, non-opioid-dependent women. Possible risks to fecundability and pregnancy viability are relevant to patients and providers when evaluating pain management approaches.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001247","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T02:29:57Z","timestamp":1596853797000},"page":"844-851","source":"Crossref","is-referenced-by-count":12,"title":["Is Opioid Use Safe in Women Trying to Conceive?"],"prefix":"10.1097","volume":"31","author":[{"given":"Kerry S.","family":"Flannagan","sequence":"first","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunni L.","family":"Mumford","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey A.","family":"Sjaarda","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie G.","family":"Radoc","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria C.","family":"Andriessen","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Zolton","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"},{"name":"Program in Reproductive Endocrinology and Gynecology,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, School of Medicine, University of Utah, Salt Lake City, UT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique F.","family":"Schisterman","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of Intramural Population Health Research,Eunice Kennedy ShriverNational Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"R2-20230908","first-page":"563","article-title":"Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature.","volume":"4","author":"Yazdy","year":"2015","journal-title":"J Pediatr Genet"},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"314.e1","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects.","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000002093","article-title":"Patterns of opioid prescription and use after cesarean delivery.","volume":"130","author":"Bateman","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.drugalcdep.2018.04.011","article-title":"Geographic variation in postpartum prescription opioid use: opportunities to improve maternal safety.","volume":"188","author":"Becker","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jmig.2017.11.005","article-title":"Opioid prescription and patient use after gynecologic procedures: a survey of patients and providers.","volume":"25","author":"Griffith","year":"2018","journal-title":"J Minim Invasive Gynecol"},{"key":"R8-20230908","first-page":"103","article-title":"Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study.","volume":"32","author":"McInerney","year":"2017","journal-title":"Hum Reprod"},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health.","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med"},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/humrep\/dev329","article-title":"Expanded findings from a randomized controlled trial of preconception low-dose aspirin and pregnancy loss.","volume":"31","author":"Mumford","year":"2016","journal-title":"Hum Reprod"},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/ppe.12088","article-title":"A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics.","volume":"27","author":"Schisterman","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: practical guide for clinicians.","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2017.06.009","article-title":"Impact of the opioid system on the reproductive axis.","volume":"108","author":"B\u00f6ttcher","year":"2017","journal-title":"Fertil Steril"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1210\/en.2012-1470","article-title":"Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice.","volume":"153","author":"Roa","year":"2012","journal-title":"Endocrinology"},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.mayocp.2016.04.022","article-title":"Adult-onset hypogonadism.","volume":"91","author":"Khera","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/jcem-60-2-299","article-title":"Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.","volume":"60","author":"Gilbeau","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems.","volume":"31","author":"Vuong","year":"2010","journal-title":"Endocr Rev"},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"906723","DOI":"10.1155\/2014\/906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.","volume":"2014","author":"Whiteman","year":"2014","journal-title":"J Pregnancy"},{"key":"R20-20230908","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age\u2013United States, 2008-2012.","volume":"64","author":"Ailes","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/AOG.0000000000002741","article-title":"Frequency of opioid dispensing after vaginal delivery.","volume":"132","author":"Prabhu","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R22-20230908","first-page":"PCC.12f01371","article-title":"Toxicologic testing for opiates: understanding false-positive and false-negative test results.","volume":"14","author":"Keary","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.fertnstert.2018.06.023","article-title":"Opioid dispensing patterns after oocyte retrieval.","volume":"110","author":"Bortoletto","year":"2018","journal-title":"Fertil Steril"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T11:21:45Z","timestamp":1694172105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001247","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}